Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

Tumor necrosis factor-alpha (TNF-α), IL-6, and IL-17 are pivotal mediators in conditions like RA and psoriasis. The IL-1 family, including IL-1β and IL-18, further exacerbates tissue damage by ...